BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24144448)

  • 1. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
    Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
    Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of whole-body oncologic PET with time-of-flight and point-spread function for the hybrid PET/MR system.
    Shang K; Cui B; Ma J; Shuai D; Liang Z; Jansen F; Zhou Y; Lu J; Zhao G
    Eur J Radiol; 2017 Aug; 93():70-75. PubMed ID: 28668434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of time of flight and point spread function on quantitative parameters of lung lesions in
    Huang K; Feng Y; Liang W; Li L
    BMC Med Imaging; 2021 Nov; 21(1):169. PubMed ID: 34773998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.
    Kawashima K; Kato K; Tomabechi M; Matsuo M; Otsuka K; Ishida K; Nakamura R; Ehara S
    Br J Radiol; 2016 Jul; 89(1063):20150938. PubMed ID: 27146065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does PET SUV Harmonization Affect PERCIST Response Classification?
    Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
    J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
    Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
    Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
    Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
    Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.
    Rogasch JM; Hofheinz F; Lougovski A; Furth C; Ruf J; Großer OS; Mohnike K; Hass P; Walke M; Amthauer H; Steffen IG
    EJNMMI Phys; 2014 Dec; 1(1):12. PubMed ID: 26501454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of both time of flight and point spread function in brain PET image reconstruction.
    Shao X; Shao X; Wang X; Wang Y
    Nucl Med Commun; 2016 Apr; 37(4):422-7. PubMed ID: 26637071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.
    Rogasch JM; Steffen IG; Hofheinz F; Großer OS; Furth C; Mohnike K; Hass P; Walke M; Apostolova I; Amthauer H
    EJNMMI Res; 2015; 5():31. PubMed ID: 25992306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of [
    Liu Y; Gao MJ; Zhou J; Du F; Chen L; Huang ZK; Hu JB; Lou C
    BMC Med Imaging; 2021 Sep; 21(1):133. PubMed ID: 34530768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
    Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
    J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
    Bellevre D; Blanc Fournier C; Switsers O; Dugué AE; Levy C; Allouache D; Desmonts C; Crouet H; Guilloit JM; Grellard JM; Aide N
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1103-12. PubMed ID: 24562642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
    Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of
    Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
    Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of PET image reconstruction using a spatial resolution model.
    Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
    Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
    Teoh EJ; McGowan DR; Macpherson RE; Bradley KM; Gleeson FV
    J Nucl Med; 2015 Sep; 56(9):1447-52. PubMed ID: 26159585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.